Shandong Weigao GP Medical Polymer Co is a medical device manufacturer engaged in the research, development, production, and sale of medical device products, orthopaedic products, interventional products, pharma packaging products, and blood management products. The company operates through six divisions, with interventional products produced by subsidiary Argon Medical Devices Holding, Inc. and orthopaedic products managed by Shandong Weigao Orthopaedic Device Company Limited. Pharma packaging is handled by Shandong Weigao Puri Pharmaceutical Packaging Co., Ltd. The company serves domestic and international markets, establishing joint ventures in Indonesia for localized operations and sales. It is part of the Weigao Group ecosystem, which includes Weihai Weigao International Medical Investment Holdings Co., Ltd. and Weihai Huadong Automation Co., Ltd. The company is pursuing an asset swap with Weigao Blood Purification to integrate blood purification and biopharmaceutical upstream businesses, positioning itself as a consolidated platform for the group's medical device assets.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Medical Devices Homepage weigaogroup.com
Sector Healthcare IR page weigaogroup.com/index/investor.html
Tags
medical devices, orthopaedic implants, interventional products, pharma packaging, blood management, syringes, blood purification, biopharmaceutical upstream, clinical care, medical polymers, Argon Medical Devices Holding Inc., Shandong Weigao Orthopaedic Device Company Limited, Shandong Weigao Puri Pharmaceutical Packaging Co. Ltd., Weigao Blood Purification, Weigao Holding, Weihai Weigao International Medical Investment Holdings Co. Ltd., Weihai Huadong Automation Co. Ltd.
Press page —

Metrics

Valuation  
Market cap HK$ 14.02B
Market cap (USD) $ 1.787B
P/E 7.91
PEG —
P/BV 0.47
P/S 0.88
P/OCF 4.34
P/FCF —
Dividend yield 5.4%
Turnover / mcap 0.16%
Returns  
ROE 6.3%
ROI 5.9%
ROIC 5.9%
Profit margin 12.0%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -16.0%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 6.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 13.389B 13.087B 13.229B 13.619B 13.152B 11.345B 10.384B 8.809B 6.293B 6.73B 5.919B 5.278B 4.613B 3.689B 3.181B 2.463B
Net profit 1.612B 2.067B 2.002B 2.723B 2.245B 2.03B 1.85B 1.473B 1.73B 1.106B 1.113B 1.085B 387.984M 996.486M 3.462B 799.072M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 4.72 4.04 11.15 10.51 — 18.98 — 5.23 4.49 — — — — — — —
Price performance 12m 0.19 -0.63 0 — — — — 0.15 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

OVERSEAS REGULATORY ANNOUNCEMENT Bull 0 Bear 0 Routine
OVERSEAS REGULATORY ANNOUNCEMENT Bull 0 Bear 0 Routine

Prompts

Shandong Weigao GP Medical Polymer Co (ticker 1066), listed in Hong Kong.

ETFs Holding Shandong Weigao GP Medical Polymer Co

ETF Weight in ETF Shares Market value As of
AVEE 0.13% 399,200 $ 166.25K Nov 16, 2026
REMG 0.08% 204,000 $ 82.455K Jun 30, 2026
AVES 0.04% 1,248,400 $ 519.906K Nov 16, 2026
AVSE 0.04% 195,200 $ 81.293K Nov 16, 2026
DFEM 0.02% 4,014,400 $ 1.681M Nov 12, 2026
DFEV 0.02% 917,600 $ 384.251K Nov 12, 2026
DFSE 0.01% 183,600 $ 76.884K Nov 12, 2026
AVEM 0.01% 7,638,800 $ 3.181M Nov 16, 2026
DFAE 0.01% 1,997,600 $ 836.508K Nov 12, 2026
DFAX 0.00% 71,200 $ 29.815K Nov 12, 2026